Government-backed population genomics projects escalate demand, while AI and long-read sequencing tech enhance data analysis ...

The market for whole genome and exome sequencing is set to grow significantly, driven by decreasing sequencing costs and a ...

A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...

The AHA recommended whole exome or whole genome sequencing as first-line diagnostic tools for mitochondrial diseases.

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the company is developing its ...

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced ultraRapid Whole Genome Sequencing, offering ...

BOSTON--(BUSINESS WIRE)--Variantyx, a leader in high complexity hereditary disease testing, today announced that they secured $20M in funding for their Whole Genome Sequencing (WGS)-based testing ...

A combined whole-genome sequencing approach could be used to detect and monitor cancer from liquid biopsies. It is challenging to monitor cancer from liquid biopsies due to the low concentrations of ...

Scientists sequence hundreds of thousands of genomes for crucial large-scale research efforts, such as population genomics initiatives that process more than 10,000 samples per year, to explore ...